Skip to main content

Table 4 Adverse events of included trials on Huaiqihuang for Henoch-Schönlein purpura nephritis

From: Chinese patent herbal medicine Huaiqihuang for Henoch-Schonlein purpura nephritis in children: a systematic review of randomized controlled trials

Study ID

Sample size (E/C)

Adverse events cases

Experimental group (n)

Control group (n)

Duan CR 2017 [13]

36/36

E:0/36; C:0/36

Reported no occurrence

Reported no occurrence

Han DX 2014 [14]

38/35

E:2/38; C:7/35

Hypertension; secondary infection (Total 2)

Hypertension; secondary infection; mental symptoms (Total 7)

Lu W 2015 [15]

20/20

E:6/20; C:7/20

Adverse reaction of glucocorticoid (2)

gastrointestinal discomfort (3)

respiratory tract infection (1)

Adverse reaction of glucocorticoid (3)

gastrointestinal discomfort (3)

respiratory tract infection (1)

Peng YH 2014 [16]

28/26

E:NR; C:NR

NR

NR

Shi Z 2019 [17]

15/15

E:1/15; C:6/15

Diarrhea (1)

Itching(1), diarrhea(2), rash(1), nausea(1), dizziness (1)

Yuan TT 2020 [18]

47/47

E:NR; C:NR

NR

NR

Zhou DJ a 2013 [19]

10/10

E:NR; C:NR

NR

NR

Zhou DJ b 2013 [19]

5/5

E:NR; C:NR

NR

NR

  1. Abbreviations: RCTs Randomized controlled trials, HQH Huaiqihuang, E Experimental group, C Control group, NR Not reported